Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Helson

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Nanobiotechnology|December 17, 2013
Mitigating prolonged QT interval in cancer nanodrug development for accelerated clinical translationAmalendu P Ranjan, Anindita Mukerjee, Lawrence Helson, et al.
Journal of Nanobiotechnology|September 4, 2012
Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapyAmalendu P Ranjan, Anindita Mukerjee, Lawrence Helson, et al.
Bioconjugate Chemistry|May 18, 2006
Single-drug multiligand conjugates: synthesis and preliminary cytotoxicity evaluation of a paclitaxel-dipeptide "scorpion" moleculeAhmad Safavy, Kevin P Raisch, Damien Matusiak, et al.
Anticancer Research|September 10, 2014
Liposomes ameliorate Crizotinib- and Nilotinib-induced inhibition of the cardiac IKr channel and QTc prolongationGeorge M Shopp, Lawrence Helson, Annie Bouchard, et al.
Molecular Pharmaceutics|March 29, 2013
Polymeric curcumin nanoparticle pharmacokinetics and metabolism in bile duct cannulated ratsPeng Zou, Lawrence Helson, Anirban Maitra, et al.
Anticancer Research|October 13, 2012
Tissue distribution of (Lipocurc™) liposomal curcumin and tetrahydrocurcumin following two- and eight-hour infusions in Beagle dogsDharmendr Matabudul, Kresimir Pucaj, Gordon Bolger, et al.
In Vivo (Athens, Greece)|July 7, 2016
In Vitro Study of a Liposomal Curcumin Formulation (Lipocurc™): Toxicity and Biological Activity in Synovial Fibroblasts and MacrophagesBurkhard Kloesch, Lukas Gober, Silvia Loebsch, et al.
Anticancer Research|September 12, 2013
Efficacy of liposomal curcumin in a human pancreatic tumor xenograft model: inhibition of tumor growth and angiogenesisAmalendu P Ranjan, Anindita Mukerjee, Lawrence Helson, et al.
Anticancer Research|October 13, 2012
Infusion pharmacokinetics of Lipocurc™ (liposomal curcumin) and its metabolite tetrahydrocurcumin in Beagle dogsLawrence Helson, Gordon Bolger, Muhammed Majeed, et al.
Anticancer Research|July 3, 2017
Distribution and Metabolism of Lipocurc™ (Liposomal Curcumin) in Dog and Human Blood Cells: Species Selectivity and Pharmacokinetic RelevanceGordon T Bolger, Albert Licollari, Aimin Tan, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Nanobiotechnology|December 17, 2013
Mitigating prolonged QT interval in cancer nanodrug development for accelerated clinical translationAmalendu P Ranjan, Anindita Mukerjee, Lawrence Helson, et al.
Journal of Nanobiotechnology|September 4, 2012
Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapyAmalendu P Ranjan, Anindita Mukerjee, Lawrence Helson, et al.
Bioconjugate Chemistry|May 18, 2006
Single-drug multiligand conjugates: synthesis and preliminary cytotoxicity evaluation of a paclitaxel-dipeptide "scorpion" moleculeAhmad Safavy, Kevin P Raisch, Damien Matusiak, et al.
Anticancer Research|September 10, 2014
Liposomes ameliorate Crizotinib- and Nilotinib-induced inhibition of the cardiac IKr channel and QTc prolongationGeorge M Shopp, Lawrence Helson, Annie Bouchard, et al.
Molecular Pharmaceutics|March 29, 2013
Polymeric curcumin nanoparticle pharmacokinetics and metabolism in bile duct cannulated ratsPeng Zou, Lawrence Helson, Anirban Maitra, et al.
Anticancer Research|October 13, 2012
Tissue distribution of (Lipocurc™) liposomal curcumin and tetrahydrocurcumin following two- and eight-hour infusions in Beagle dogsDharmendr Matabudul, Kresimir Pucaj, Gordon Bolger, et al.
In Vivo (Athens, Greece)|July 7, 2016
In Vitro Study of a Liposomal Curcumin Formulation (Lipocurc™): Toxicity and Biological Activity in Synovial Fibroblasts and MacrophagesBurkhard Kloesch, Lukas Gober, Silvia Loebsch, et al.
Anticancer Research|September 12, 2013
Efficacy of liposomal curcumin in a human pancreatic tumor xenograft model: inhibition of tumor growth and angiogenesisAmalendu P Ranjan, Anindita Mukerjee, Lawrence Helson, et al.
Anticancer Research|October 13, 2012
Infusion pharmacokinetics of Lipocurc™ (liposomal curcumin) and its metabolite tetrahydrocurcumin in Beagle dogsLawrence Helson, Gordon Bolger, Muhammed Majeed, et al.
Anticancer Research|July 3, 2017
Distribution and Metabolism of Lipocurc™ (Liposomal Curcumin) in Dog and Human Blood Cells: Species Selectivity and Pharmacokinetic RelevanceGordon T Bolger, Albert Licollari, Aimin Tan, et al.
Pageof 3